Effect of Dairy Consumption on Glycemic Control, Body Weight and Cardiovascular Risk in Patients With Type 2 Diabetes
Completed · Not applicable
Conditions studied: Type 2 Diabetes
In brief
This is a randomized prospective clinical study in patients with type 2 diabetes to evaluate the effect of dairy products with full or low fat on glycemic control and cardio-metabolic risk factors in comparison to a regular diet.
Key facts
- Study ID
- NCT02895867
- Run by
- Joslin Diabetes Center
- People needed
- 112
- Starts
- 2016-05-01
- Expected to finish
- 2018-08-01
- Last updated by the study team
- 2026-05-28
Who can join
Age: 18 and older, up to 75. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Having type 2 diabetes for at least three months prior to screening and treated with any antihyperglycemic medication
- A1C ≥7 %
- Consuming <3 servings of dairy products per day
- On stable dose of diabetes, blood pressure or cholesterol medications for 3 months
- Body weight is within 10% of current weight over the last 6 months before starting the study
You may not qualify if…
- Pregnancy or lactation
- Lactose intolerance
- Allergy to milk or any of its components
- Use of orlistat
- History of pancreatitis
- History of gastric bypass surgery or sleeve gastrectomy
- Active malignancy
- History of recent cardiovascular event
- Having a heart pacemaker
- Enrollment in other studies that may affect study outcomes
Where it is running
- Joslin Diabetes Center — Boston, Massachusetts, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.